143 related articles for article (PubMed ID: 33025600)
1. The interaction of neonatal abstinence syndrome and opioid use disorder treatment availability for women insured by medicaid.
Reising VA; Horne A; Bennett AC
Public Health Nurs; 2021 Jan; 38(1):98-105. PubMed ID: 33025600
[TBL] [Abstract][Full Text] [Related]
2. Maternal Opioid Use Disorder and Neonatal Abstinence Syndrome Among Rural US Residents, 2007-2014.
Kozhimannil KB; Chantarat T; Ecklund AM; Henning-Smith C; Jones C
J Rural Health; 2019 Jan; 35(1):122-132. PubMed ID: 30370563
[TBL] [Abstract][Full Text] [Related]
3. Pregnant women with opioid use disorder and their infants in three state Medicaid programs in 2013-2016.
Clemans-Cope L; Lynch V; Howell E; Hill I; Holla N; Morgan J; Johnson P; Cross-Barnet C; Thompson JA
Drug Alcohol Depend; 2019 Feb; 195():156-163. PubMed ID: 30677745
[TBL] [Abstract][Full Text] [Related]
4. Rural and Appalachian Disparities in Neonatal Abstinence Syndrome Incidence and Access to Opioid Abuse Treatment.
Brown JD; Goodin AJ; Talbert JC
J Rural Health; 2018 Dec; 34(1):6-13. PubMed ID: 28685864
[TBL] [Abstract][Full Text] [Related]
5. Association Among County-Level Economic Factors, Clinician Supply, Metropolitan or Rural Location, and Neonatal Abstinence Syndrome.
Patrick SW; Faherty LJ; Dick AW; Scott TA; Dudley J; Stein BD
JAMA; 2019 Jan; 321(4):385-393. PubMed ID: 30694320
[TBL] [Abstract][Full Text] [Related]
6. Association between punitive policies and neonatal abstinence syndrome among Medicaid-insured infants in complex policy environments.
Faherty LJ; Heins S; Kranz AM; Patrick SW; Stein BD
Addiction; 2022 Jan; 117(1):162-171. PubMed ID: 34096671
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and Geographic Distribution of Obstetrician-Gynecologists Who Treat Medicaid Enrollees and Are Trained to Prescribe Buprenorphine.
Nguemeni Tiako MJ; Culhane J; South E; Srinivas SK; Meisel ZF
JAMA Netw Open; 2020 Dec; 3(12):e2029043. PubMed ID: 33306115
[TBL] [Abstract][Full Text] [Related]
8. State Strategies to Address Opioid Use Disorder Among Pregnant and Postpartum Women and Infants Prenatally Exposed to Substances, Including Infants with Neonatal Abstinence Syndrome.
Kroelinger CD; Rice ME; Cox S; Hickner HR; Weber MK; Romero L; Ko JY; Addison D; Mueller T; Shapiro-Mendoza C; Fehrenbach SN; Honein MA; Barfield WD
MMWR Morb Mortal Wkly Rep; 2019 Sep; 68(36):777-783. PubMed ID: 31513558
[TBL] [Abstract][Full Text] [Related]
9. A state-level study of opioid use disorder treatment access and neonatal abstinence syndrome.
Wolf ER; Tong ST; Sabo RT; Woolf SH; Abbinanti K; Pecsok J; Krist AH
BMC Pediatr; 2019 Oct; 19(1):371. PubMed ID: 31640614
[TBL] [Abstract][Full Text] [Related]
10. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
[TBL] [Abstract][Full Text] [Related]
11. Prenatal Substance Exposure and Neonatal Abstinence Syndrome: State Estimates from the 2016-2020 Transformed Medicaid Statistical Information System.
West KD; Ali MM; Blanco M; Natzke B; Nguyen L
Matern Child Health J; 2023 Dec; 27(Suppl 1):14-22. PubMed ID: 37219692
[TBL] [Abstract][Full Text] [Related]
12. Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol.
Bryan MA; Smid MC; Cheng M; Fortenberry KT; Kenney A; Muniyappa B; Pendergrass D; Gordon AJ; Cochran G
Addict Sci Clin Pract; 2020 Oct; 15(1):33. PubMed ID: 33129355
[TBL] [Abstract][Full Text] [Related]
13. Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers.
Cochran G; Cole ES; Warwick J; Donohue JM; Gordon AJ; Gellad WF; Bear T; Kelley D; DiDomenico E; Pringle J
Addict Sci Clin Pract; 2019 Aug; 14(1):25. PubMed ID: 31366408
[TBL] [Abstract][Full Text] [Related]
14. Geographic Disparities in Availability of Opioid Use Disorder Treatment for Medicaid Enrollees.
Abraham AJ; Andrews CM; Yingling ME; Shannon J
Health Serv Res; 2018 Feb; 53(1):389-404. PubMed ID: 28345210
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of birth defects among infants with neonatal abstinence syndrome in Illinois, 2015-2016.
Fornoff J; Sandidge T
Birth Defects Res; 2021 Jan; 113(2):134-143. PubMed ID: 32896979
[TBL] [Abstract][Full Text] [Related]
16. Conceptualizing Neonatal Abstinence Syndrome as a Cascade of Care: A Qualitative Study With Healthcare Providers in Ohio.
Syvertsen JL; Toneff H; Madden DR; Clapp JD
Adv Neonatal Care; 2018 Dec; 18(6):488-499. PubMed ID: 30234507
[TBL] [Abstract][Full Text] [Related]
17. Neonatal Abstinence Syndrome (NAS) in Southwestern Border States: Examining Trends, Population Correlates, and Implications for Policy.
Hussaini KS; Garcia Saavedra LF
Matern Child Health J; 2018 Sep; 22(9):1352-1359. PubMed ID: 29572587
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Maternal-Risk Factors Related to Neonatal Abstinence Syndrome in a Commercial Claims Database: 2011-2015.
Dave CV; Goodin A; Zhu Y; Winterstein A; Wang X; Alrwisan A; Hartzema A
Pharmacotherapy; 2019 Oct; 39(10):1005-1011. PubMed ID: 31361913
[TBL] [Abstract][Full Text] [Related]
19. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.
Cole ES; DiDomenico E; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kim JY; Kmiec J; Kelley D; Donohue JM
J Gen Intern Med; 2019 Jun; 34(6):936-943. PubMed ID: 30887440
[TBL] [Abstract][Full Text] [Related]
20. Neonatal Abstinence Syndrome: Trend and Expenditure in Louisiana Medicaid, 2003-2013.
Okoroh EM; Gee RE; Jiang B; McNeil MB; Hardy-Decuir BA; Zapata AL
Matern Child Health J; 2017 Jul; 21(7):1479-1487. PubMed ID: 28168591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
